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Introduction
As mentioned by Biesecker et al., (2020)

In the OR the anesthesia provider (e.g.,

“Malignant hyperthermia (MH) is a

physician anesthesiologist or certified

MH is a hypermetabolic state that

syndrome of acutely disordered skeletal

registered nurse anesthetist) is

arises through increased calcium ions

muscle excitation-contraction coupling”

managing the autonomic nervous

within the cell. A regulator of calcium

(p. 1277). MH has a sudden onset and if

system through pharmacologic

balance is the ryanodine receptor

not treated promptly can lead to

manipulation, oxygenating & ventilating

found at the sarcoplasmic reticulum

detrimental complications and even

the airway structures, and assessing

in smooth muscle tissue. As stated by

death.

hemodynamic changes on the monitor.

Litman et al., (2018) “abnormalities of

MH exacerbation commonly includes

cell is the primary incident of this

accumulation of excessive

the following:

myoplasmic calcium in the presence

hypermetabolic state, leading to
numerous physiological and clinical

•
•

Variable blood pressure (low or
high)

inhaled anesthetics which are frequently
used by anesthesia providers.

Tachycardia (greater than 100
beats per minute)

effects. MH is induced with the use of
neuromuscular blocking agents and

•

Hyperthermia (greater than 100.4
degrees Fahrenheit)

MH is a complex disorder that can be

•

Tachypnea (respiratory rate

genetically predisposed and as stated by

greater than 20 breathes per

Litman et al., (2018) “700 variants have

minute)

been identified in RYR1; however, only

•

Elevated carbon dioxide

35 have been functionally validated as

production (end-tidal carbon

MH–causative pathogenic variants”

dioxide greater than 45 mm Hg)

(p.159). MH exacerbation is rare, but as a

•

student registered nurse anesthetist
(SRNA) being knowledgeable in

Progression of Condition

of one of the anesthetic triggering

MH is a multifaceted condition that has

Griggs, S. M. (2020). Malignant

increased oxygen consumption, while decreasing oxygen supply leading to anaerobic

cannot be managed solely by one provider,

genetic predispositions and can be

hyperthermia of anesthesia. The

metabolism. This anaerobic state causes insufficient production of energy leading to

thus when recognized immediate steps

induced with the use of certain anesthetic

American Society of Anesthesiologists,

dysfunction of the body, thus presenting the numerous clinical effects that are seen with MH

should be taken by the OR staff. It is

medications. Thus, the use of genetic

Inc. Wolters Kluwer Health, Inc. .

(Hopkins et al., 2020). If MH is not promptly managed there can be severe damage including

recommended that there be MH specific

testing, biopsy and thorough patient

https://doi.org/10.32388/hjfhq0

lactic acidosis from anerobic metabolism, rhabdomyolysis leading to compartment

protocols, and carts that are readily

interview prior to anesthesia is imperative

Ibarra Moreno, C. A., Hu, S., Kraeva, N.,

syndrome, acute renal failure, disseminated coagulation cascade, and even cardiac

available. An alternative resource is stated

in preventing this lethal event. Further,

Schuster, F., Johannsen, S., Rueffert, H.,

dysrhythmias leading to cardiac arrest. (Hopkins et al., 2020)

by Riazi et al., “In the United States a

use of simulations to practice the course

Klingler, W., Heytens, L., & Riazi, S.

“hotline’’ has been established to provide

of MH can be effective in preparing the

(2019). An assessment of Penetrance

emergency assistance (1-800-644-9737) in

anesthesia provider and OR staff in

and clinical expression of malignant

the management of MH.” (2018, p.713).

immediate management.

hyperthermia in individuals carrying

Exposure to trigg@ring .11nestheUc .119ent
VolatUe inhalational anesthetic gases
SUccinykholine

Skelebl musca. call

agents” (p. 159). MH does have
hereditary significance, and if a family
member has had a MH suspected

of correcting the hypermetabolic process is

It should be emphasized that preventative

mutations. Anesthesiology, 131(5), 983–

the sole way to prevent further

measures of MH supersedes the use of

991.

complications.

pharmacologic methods to prevent the

https://doi.org/10.1097/aln.0000000000

Treatment

progression of this condition. MH signs

002813

and symptoms are warnings to an

Litman, R. S., Griggs, S. M., Dowling, J. J.,

Recommended interventions of reversing

impending crisis and warrant immediate

& Riazi, S. (2018). Malignant

MH:

intervention. The anesthesia provider

hyperthermia susceptibility and related

•

needs to promptly alert the necessary

diseases. Anesthesiology, 128(1), 159–

reaction precaution should be taken.
Genetic testing and MH contracture
biopsy can be performed to assess a
patient’s susceptibility to a MH
reaction prior to a planned procedure

(volatile anesthetic or intravenous

medical staff, implement measures to

167.

prevent progression and keep the patient

https://doi.org/10.1097/aln.0000000000

•

Turn off and remove vaporizer.

safe during their anesthetic care.

001877

•

Provide 100% oxygen at maximum

Wassink, G., Davidson, J. O., Lear, C. A.,

flow.

Juul, S. E., Northington, F., Bennet, L., &

•

Musculoskeletal issues
(rhabdomyolysis, and muscle

managing clinical changes, and

rigidity)

•

promoting preventive measures will
allow for improved patient outcomes

MH has no cardinal characteristics, but

within the operating room (OR).

complications occur in a rapid and
random sequence. Thus, if these

•
Heat production
Muscle ceU hypoxia and death

symptoms present and a causative agent
is not promptly identified, then
immediate suspicion should be MH.
(Riazi et al., 2018)

Malign.11nt hyperl:hermi.111 syndrome
Metabolic and respiratory acidosis
Muscular rigidity
Rhabdomyolysis
Hyperthermia

Uptodate. (n.d.). [Physiologic image of malignant hyperthermia]. Retrieved July 10, 2022,
from https://www.uptodate.com/contents/malignant-hyperthermia-diagnosis-andmanagement-of-acute-crisis

Eliminate the suspected agent
anesthetic).

where anesthetic triggers could be
utilized (Ibarra-Moreno, 2019).

diagnostic ryanodine receptor 1 gene

When MH is recognized prompt initiation

Metabolic acidosis (elevated

identifying signs and symptoms,

Dowling, J. J., Riazi, S., Litman, R. S., &

MH is a complication of anesthesia that

hydrogen ions)
•
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Conclusion

Accumulation of calcium leads to an accelerated use of energy within the cell causing

the ryanodine receptor result in the

Rapid movement of calcium ions into the

Implications for
Nursing Care

•

Increase minute ventilation 2 to 3
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times normal.
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Insert activated charcoal filters on
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inspiratory and expiratory limbs of

5654.
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Administer symptom management
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medications (e.g., dantrolene
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sodium, sodium bicarbonate,

management of malignant

antiarrhythmic, insulin, or blood

hyperthermia. Canadian Journal of
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Active body cooling.
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As mentioned, if a MH protocol or
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resource is available refer to the facility’s
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policies in managing this condition.
(Hopkins et al., 2021)

